Position
SIMPLEX TRADING, LLC in UroGen Pharma Ltd.
Back to the book · All holders of URGN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$43.9K$23.42 → $17.98
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 22.1K | $517.8K | — | — | — | 0.0% |
| Q1 2026 | 8.07K | $145K | $17.98 | −$43.9K | −$328.9K | 0.0% |